Compare BCML & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCML | SMTI |
|---|---|---|
| Founded | 2004 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 338.6M | 208.8M |
| IPO Year | 2018 | 2008 |
| Metric | BCML | SMTI |
|---|---|---|
| Price | $31.39 | $22.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $34.00 | $34.00 |
| AVG Volume (30 Days) | ★ 44.7K | 40.8K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.09% | N/A |
| EPS Growth | ★ 3.81 | N/A |
| EPS | ★ 0.75 | 0.05 |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | $13.71 | $17.31 |
| Revenue Next Year | $5.25 | $12.48 |
| P/E Ratio | ★ $40.81 | $419.40 |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $26.06 | $16.05 |
| 52 Week High | $33.15 | $35.70 |
| Indicator | BCML | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 60.26 | 53.38 |
| Support Level | $27.33 | $18.20 |
| Resistance Level | $32.91 | $24.17 |
| Average True Range (ATR) | 0.71 | 1.21 |
| MACD | 0.01 | -0.22 |
| Stochastic Oscillator | 90.66 | 34.93 |
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.